Earnings Call · Q3 FY2022·2022-11-08

Q3 22EPS +100.00%*·Rev n/aQ2 22EPS +3.95%·Rev n/aQ1 22EPS +67.16%·Rev n/aQ4 21EPS +47.67%·Rev n/a⚠ consensus missing

ADC Therapeutics SA ADCT

Amanda Hamilton — Investor Relations or Communications

Ameet Mallik — Chief Executive Officer

Joe Camardo — Likely Chief Medical Officer or similar clinical role

Jenn Creel — Chief Financial Officer

−2.8%1d on move date−3.4% vs SPY3d−6.1%5d−2.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADCT calls or request research access.

More ADCT calls Browse calls Request research access